Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

ProGenTech Closes $21 Million Financing

publication date: Apr 2, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

ProGenTech of Shanghai and Emeryville, CA raised $21 million in a Series C financing. The round was led by Bay City Capital of San Francisco and DT Capital of Shanghai. ProGenTech is developing an automated nucleic acid purification system with a cassette-based technology that is designed to keep samples free of user contamination. ProGenTech was established in 2005 and now has 40 employees. Its first product, the Entura, was launched in Asia in November 2007. More details...

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...